Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 1
1971 1
1977 2
1979 4
1982 7
1983 6
1984 4
1985 4
1986 7
1987 5
1988 9
1989 1
1990 6
1991 4
1992 2
1993 5
1994 6
1995 1
1996 8
1997 8
1998 10
1999 12
2000 7
2001 6
2002 3
2003 3
2004 2
2005 8
2006 5
2007 7
2008 8
2009 11
2010 7
2011 14
2012 14
2013 15
2014 10
2015 14
2016 13
2017 18
2018 15
2019 13
2020 23
2021 27
2022 26
2023 20
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Results by year

Filters applied: . Clear all
Page 1
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
Ahn MJ, Cho BC, Felip E, Korantzis I, Ohashi K, Majem M, Juan-Vidal O, Handzhiev S, Izumi H, Lee JS, Dziadziuszko R, Wolf J, Blackhall F, Reck M, Bustamante Alvarez J, Hummel HD, Dingemans AC, Sands J, Akamatsu H, Owonikoko TK, Ramalingam SS, Borghaei H, Johnson ML, Huang S, Mukherjee S, Minocha M, Jiang T, Martinez P, Anderson ES, Paz-Ares L; DeLLphi-301 Investigators. Ahn MJ, et al. N Engl J Med. 2023 Nov 30;389(22):2063-2075. doi: 10.1056/NEJMoa2307980. Epub 2023 Oct 20. N Engl J Med. 2023. PMID: 37861218 Clinical Trial.
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.
Nakagawa K, Garon EB, Seto T, Nishio M, Ponce Aix S, Paz-Ares L, Chiu CH, Park K, Novello S, Nadal E, Imamura F, Yoh K, Shih JY, Au KH, Moro-Sibilot D, Enatsu S, Zimmermann A, Frimodt-Moller B, Visseren-Grul C, Reck M; RELAY Study Investigators. Nakagawa K, et al. Lancet Oncol. 2019 Dec;20(12):1655-1669. doi: 10.1016/S1470-2045(19)30634-5. Epub 2019 Oct 4. Lancet Oncol. 2019. PMID: 31591063 Clinical Trial.
COVID-19 vaccine-associated organizing pneumonia.
Yoshikawa T, Tomomatsu K, Okazaki E, Takeuchi T, Horio Y, Kondo Y, Oguma T, Asano K. Yoshikawa T, et al. Among authors: horio y. Respirol Case Rep. 2022 Mar 29;10(5):e0944. doi: 10.1002/rcr2.944. eCollection 2022 May. Respirol Case Rep. 2022. PMID: 35386579 Free PMC article.
Alpha-1 antitrypsin limits neutrophil extracellular trap disruption of airway epithelial barrier function.
Hudock KM, Collins MS, Imbrogno MA, Kramer EL, Brewington JJ, Ziady A, Zhang N, Snowball J, Xu Y, Carey BC, Horio Y, O'Grady SM, Kopras EJ, Meeker J, Morgan H, Ostmann AJ, Skala E, Siefert ME, Na CL, Davidson CR, Gollomp K, Mangalmurti N, Trapnell BC, Clancy JP. Hudock KM, et al. Among authors: horio y. Front Immunol. 2023 Jan 10;13:1023553. doi: 10.3389/fimmu.2022.1023553. eCollection 2022. Front Immunol. 2023. PMID: 36703990 Free PMC article.
Embryonic regulation of the mouse hematopoietic niche.
Sugiyama D, Inoue-Yokoo T, Fraser ST, Kulkeaw K, Mizuochi C, Horio Y. Sugiyama D, et al. Among authors: horio y. ScientificWorldJournal. 2011;11:1770-80. doi: 10.1100/2011/598097. Epub 2011 Oct 18. ScientificWorldJournal. 2011. PMID: 22125435 Free PMC article. Review.
Asthma exacerbation associated with COVID-19 pneumonia.
Ono Y, Obayashi S, Horio Y, Niimi K, Hayama N, Ito Y, Oguma T, Asano K. Ono Y, et al. Among authors: horio y. Allergol Int. 2021 Jan;70(1):129-130. doi: 10.1016/j.alit.2020.07.002. Epub 2020 Jul 27. Allergol Int. 2021. PMID: 32732153 Free PMC article. No abstract available.
375 results